Found: 114
Select item for more details and to access through your institution.
Molecular aspects of osteopathy in type 1 Gaucher disease: correlation between genetics and bone density.
- Published in:
- Rheumatology International, 2008, v. 28, n. 9, p. 873, doi. 10.1007/s00296-008-0550-7
- By:
- Publication type:
- Article
A 10‐year follow‐up of high‐dose ambroxol treatment combined with enzyme replacement therapy for neuropathic Gaucher disease.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1396, doi. 10.1002/ajh.27302
- By:
- Publication type:
- Article
Upgrading the evidence for the use of ambroxol in Gaucher disease and GBA related Parkinson: Investigator initiated registry based on real life data.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. 545, doi. 10.1002/ajh.26131
- By:
- Publication type:
- Article
Outcomes after 8 years of eliglustat therapy for Gaucher disease type 1: Final results from the Phase 2 trial.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. 29, doi. 10.1002/ajh.25300
- By:
- Publication type:
- Article
Rapid intravenous infusion of velaglucerase‐alfa in adults with type 1 Gaucher disease.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 9, p. E246, doi. 10.1002/ajh.25205
- By:
- Publication type:
- Article
Glucosylsphingosine is a reliable response biomarker in Gaucher disease.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 6, p. E140, doi. 10.1002/ajh.25074
- By:
- Publication type:
- Article
Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS).
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 205, doi. 10.1002/ajh.24957
- By:
- Publication type:
- Article
Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naïve patients with Gaucher disease.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 656, doi. 10.1002/ajh.24369
- By:
- Publication type:
- Article
Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 661, doi. 10.1002/ajh.24399
- By:
- Publication type:
- Article
Seven-year safety and efficacy with velaglucerase alfa for treatment-naïve adult patients with type 1 Gaucher disease.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 7, p. 577, doi. 10.1002/ajh.24040
- By:
- Publication type:
- Article
Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry.
- Published in:
- American Journal of Hematology, 2015, v. 90, p. S12, doi. 10.1002/ajh.24063
- By:
- Publication type:
- Article
Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 7, p. 584, doi. 10.1002/ajh.24012
- By:
- Publication type:
- Article
Safety and efficacy results of switch from imiglucerase to velaglucerase alfa treatment in patients with type 1 Gaucher disease.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 7, p. 592, doi. 10.1002/ajh.24007
- By:
- Publication type:
- Article
Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double-blind, multinational, Phase 3 study.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 166, doi. 10.1002/ajh.23381
- By:
- Publication type:
- Article
Safety and efficacy of velaglucerase alfa in Gaucher disease type 1 patients previously treated with imiglucerase.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 172, doi. 10.1002/ajh.23383
- By:
- Publication type:
- Article
Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 179, doi. 10.1002/ajh.23382
- By:
- Publication type:
- Article
Anesthetic Approaches and Perioperative Complications of Total Hip Arthroplasty in Gaucher Disease: A Control-Matched Retrospective-Cohort Study.
- Published in:
- Life (2075-1729), 2023, v. 13, n. 8, p. 1716, doi. 10.3390/life13081716
- By:
- Publication type:
- Article
Simultaneous Bilateral Femoral Osteonecrosis in Gaucher Disease.
- Published in:
- Life (2075-1729), 2023, v. 13, n. 5, p. 1135, doi. 10.3390/life13051135
- By:
- Publication type:
- Article
Molecular Aspects of Gaucher Disease.
- Published in:
- Developmental Neuroscience, 1991, v. 13, n. 4/5, p. 352, doi. 10.1159/000112185
- By:
- Publication type:
- Article
Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Has Parkinson Disease Gone to the Dogs?
- Published in:
- Movement Disorders, 2023, v. 38, n. 2, p. 358, doi. 10.1002/mds.29270
- By:
- Publication type:
- Article
Substrate reduction therapy for GBA1-associated Parkinsonism: Are we betting on the wrong mouse?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease and GBA Heterozygotes.
- Published in:
- JAMA Neurology, 2014, v. 71, n. 6, p. 752, doi. 10.1001/jamaneurol.2014.313
- By:
- Publication type:
- Article
Outcome of ten years' echocardiographic follow-up in children with Gaucher disease.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Ethical considerations for enzyme replacement therapy in neuronopathic Gaucher disease.
- Published in:
- Clinical Genetics, 1998, v. 54, n. 3, p. 179, doi. 10.1111/j.1399-0004.1998.tb04281.x
- By:
- Publication type:
- Article
Thrombocytosis Associated with Enzyme Replacement Therapy in Gaucher Disease.
- Published in:
- Acta Haematologica, 2002, v. 108, n. 2, p. 94, doi. 10.1159/000064744
- By:
- Publication type:
- Article
Effect of Ozone on Red Blood Cell Enzymes and Intermediates.
- Published in:
- Acta Haematologica, 1999, v. 102, n. 3, p. 148, doi. 10.1159/000040990
- By:
- Publication type:
- Article
Pulmonary Hypertension in Two Patients with Type I Gaucher Disease while on Alglucerase Therapy.
- Published in:
- Acta Haematologica, 1997, v. 98, n. 1, p. 47, doi. 10.1159/000203562
- By:
- Publication type:
- Article
Sixteen years of prenatal consultations for the N370S/N370S Gaucher disease genotype: What have we learned?
- Published in:
- Prenatal Diagnosis, 2010, v. 30, n. 10, p. 924, doi. 10.1002/pd.2584
- By:
- Publication type:
- Article
Enzyme replacement therapy for mild patients with Gaucher disease.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 4, p. 202, doi. 10.1002/ajh.21369
- By:
- Publication type:
- Article
Using the International Gaucher Disease Registry data: Can we devise a virtuous circle for treated patients?
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 12, p. 887, doi. 10.1002/ajh.21306
- By:
- Publication type:
- Article
Rheological determinants in patients with Gaucher disease and internal inflammation.
- Published in:
- American Journal of Hematology, 2004, v. 75, n. 4, p. 190, doi. 10.1002/ajh.20011
- By:
- Publication type:
- Article
D-dimer assay in Gaucher disease: Correlation with severity of bone and lung involvement.
- Published in:
- American Journal of Hematology, 2003, v. 73, n. 4, p. 236, doi. 10.1002/ajh.10361
- By:
- Publication type:
- Article
Platelet function abnormalities in Gaucher disease patients.
- Published in:
- American Journal of Hematology, 1999, v. 61, n. 2, p. 103, doi. 10.1002/(SICI)1096-8652(199906)61:2<103::AID-AJH5>3.0.CO;2-V
- By:
- Publication type:
- Article
Abdominal ultrasound findings mimicking hematological malignancies in a study of 218 gaucher patients.
- Published in:
- American Journal of Hematology, 1997, v. 55, n. 1, p. 28, doi. 10.1002/(SICI)1096-8652(199705)55:1<28::AID-AJH5>3.0.CO;2-5
- By:
- Publication type:
- Article
HCG contamination of alglucerase: Clinical implications in low-dose regimen.
- Published in:
- American Journal of Hematology, 1994, v. 47, n. 3, p. 235, doi. 10.1002/ajh.2830470317
- By:
- Publication type:
- Article
Prevention of Lysosomal Storage Diseases and Derivation of Mutant Stem Cell Lines by Preimplantation Genetic Diagnosis.
- Published in:
- Molecular Biology International, 2012, p. 1, doi. 10.1155/2012/797342
- By:
- Publication type:
- Article
Uncomplicated outcome after anesthesia for pediatric patients with Gaucher disease.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Vitamin D Receptor (VDR) Polymorphisms in the Cardiac Variant of Gaucher Disease.
- Published in:
- Pediatric Cardiology, 2010, v. 31, n. 1, p. 30, doi. 10.1007/s00246-009-9538-7
- By:
- Publication type:
- Article
Effect of vitamin D receptor (VDR) genotypes on the risk for osteoporosis in type 1 Gaucher disease.
- Published in:
- 2010
- By:
- Publication type:
- Report
Bone Mineral Density in Gravida: Effect of Pregnancies and Breast-Feeding in Women of Differing Ages and Parity.
- Published in:
- Journal of Osteoporosis, 2014, p. 1, doi. 10.1155/2014/897182
- By:
- Publication type:
- Article
Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Bone loss and hematological malignancies in adults: a pilot study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rapid home therapy infusion of velaglucerase alfa in naïve patients with Gaucher disease.
- Published in:
- Internal Medicine Journal, 2024, v. 54, n. 3, p. 398, doi. 10.1111/imj.16179
- By:
- Publication type:
- Article
Rapid velaglucerase alfa infusion for Gaucher disease: 5‐year data.
- Published in:
- Internal Medicine Journal, 2022, v. 52, n. 9, p. 1645, doi. 10.1111/imj.15898
- By:
- Publication type:
- Article
Enzyme replacement therapy leading to improvement in myeloma indices in a patient with concomitant Gaucher disease.
- Published in:
- Internal Medicine Journal, 2022, v. 52, n. 5, p. 872, doi. 10.1111/imj.15781
- By:
- Publication type:
- Article
Impact of Gaucher disease on COVID‐19.
- Published in:
- Internal Medicine Journal, 2020, v. 50, n. 7, p. 894, doi. 10.1111/imj.14894
- By:
- Publication type:
- Article
Glucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agent.
- Published in:
- Immunology & Cell Biology, 2009, v. 87, n. 7, p. 514, doi. 10.1038/icb.2009.42
- By:
- Publication type:
- Article
Effect of Enzyme Replacement Therapy With Imiglucerase on BMD in Type 1 Gaucher Disease.
- Published in:
- Journal of Bone & Mineral Research, 2007, v. 22, n. 1, p. 119, doi. 10.1359/JBMR.061004
- By:
- Publication type:
- Article
Experts' views on COVID‐19 vaccination and the impact of the pandemic on patients with Gaucher disease.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 2, p. e135, doi. 10.1111/bjh.17693
- By:
- Publication type:
- Article